Posttransplant immune monitoring of anti-HLA antibody.
Kerman
R H
RH
University of Texas Medical School, Houston, Texas, USA.
Katz
S M
SM
Van Buren
C T
CT
Ruth
J
J
McKissick
E
E
Rasmussen
S
S
Kahan
B D
BD
D000017:ABO Blood-Group System; D016572:Cyclosporine / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis* / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D015166:Monitoring, Immunologic; D011184:Postoperative Period; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000017:ABO Blood-Group System; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone